Abstract. The spindle assembly checkpoint prevents cells from initiating anaphase until the spindle has been fully assembled. We previously isolated mitotic arrest deficient (mad) mutants that inactivate this checkpoint and thus increase the sensitivity of ceils to benomyl, a drug that interferes with mitotic spindle assembly by depolymerizing microtubules. We have cloned the MAD1 gene and show that when it is disrupted yeast cells have the same phenotype as the previously isolated mad! mutants: they fail to delay the metaphase to anaphase transition in response to microtubule depolymerization.
MAD1 gene and show that when it is disrupted yeast cells have the same phenotype as the previously isolated mad! mutants: they fail to delay the metaphase to anaphase transition in response to microtubule depolymerization.
MAD1 is predicted to encode a 90-kD coiled-coil protein. Anti-Madlp antibodies give a novel punctate nuclear staining pattern and cell fractionation reveals that the bulk of Madlp is soluble. Madlp becomes hyperphosphorylated when wild-type ceils are arrested in mitosis by benomyl treatment, or by placing a cold sensitive tubulin mutant at the restrictive temperature. This modification does not occur in Gl-arrested cells treated with benomyl or in cells arrested in mitosis by defects in the mitotic cyclin proteolysis machinery, suggesting that Madlp hyperphosphorylation is a step in the activation of the spindle assembly checkpoint. Analysis of Madlp phosphorylation in other spindle assembly checkpoint mutants reveals that this response to microtubule-disrupting agents is defective in some (mad2, bubl, and bub3) but not all (mad3, bub2) mutant strains. We discuss the possible functions of Madlp at this cell cycle checkpoint.
CURATE chromosome replication and segregation require mechanisms that can detect errors in these processes and initiate two responses: repair systems that correct the errors, and delay mechanisms that prevent the cell cycle from proceeding while the repairs are in progress. The combined detection and delay systems are known as cell cycle checkpoints or feedback controls (reviewed in Hartwell and Weinert, 1989; Murray, 1994 Murray, , 1995 .
Genetic analyses in both budding and fission yeast have identified a number of genes that play a role in ensuring that cells complete DNA replication and repair DNA damage before they enter mitosis (Weinert and Hartwell, 1988; Enoch and Nurse, 1990; AI-Khodairy and Carr, 1992; Rowley et al., 1992; Enoch et al., 1992; Weinert et al., 1994; A1-Khodairy et al., 1994 A1-Khodairy et al., , 1995 Ford et al., 1994) . For example, the RAD9 gene is required to arrest the cell cycle in response to DNA damage, but is not required for the process of DNA repair (Weinert and Hartwell, 1988) . This cell cycle control is not essential for growth in the absence of DNA damage, but irradiated rad9 cells are unable to delay their passage through mitosis in response to the damaged DNA and produce lethally damaged progeny.
The mitotic arrest caused by microtubule polymerization inhibitors suggests the existence of a spindle assembly checkpoint that monitors the status of the spindle and regulates the metaphase to anaphase transition. The ability of single improperly oriented chromosomes (Callan and Jacobs, 1957; Li and Nicklas, 1995; Rieder et al., 1994) , partially defective centromeres (Spencer and Hieter, 1992) , and excess centromeres (Futcher and Carbon, 1986 ; Wells, W., and A. W. Murray, unpublished results) to delay anaphase suggests that this checkpoint can detect subtle as welt as gross defects in the structure of the spindle. Mutants in the spindle assembly checkpoint have been identified in budding yeast. The bub (budding uninhibited )y benzimidazole; Hoyt et al., 1991) and mad (mitotic arr¢st deficient; Li and Murray, 1991) mutants were isolated from collections of mutants that failed to form colonies in the presence of low doses of benomyl, a microtubule polymerization inhibitor. The mad mutants were distinguished from mutants that affected microtubule assembly by their inability to delay cell division in response to microtubule depolymerization. The divisions that take place in the absence of a fully functional spindle lead to a high frequency of chromosome loss and cell death (Li and Murray, 1991) .
The spindle assembly checkpoint defined by the mad and leu2, 1eu2, leu2, his3, leu2, his3, leu2, his3, leu2, his3, leu2, rad9A::LEU2 madl~l.l::HlS3, Ieu2, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] 1eu2, 1eu2, leu2, leu2, leu2, 1eu2, 1eu2, 1eu2, leu2, leu2, leu2, bub mutants is expected to consist of components that detect defects in spindle structure, and a signal transduction pathway that relays this information and ultimately inhibits a target in the machinery that initiates sister chromatid separation and anaphase. In common with other cell cycle transitions a major regulator of the metaphase to anaphase transition is thought to be the kinase activity of Cdc28p-mitotic cyclin complexes (for reviews see Norbury and Nurse, 1992; Morgan, 1995) . Experiments in frog egg extracts and in yeast have shown that the ubiquitin-mediated proteolysis of mitotic cyclins and other proteins is required for sister chromatid separation and entry into the next cell cycle (Holloway et al., 1993; Surana et al., 1993) .
Little is known about the biochemical mechanism of the spindle assembly checkpoint. Previous work has shown that BUB1 encodes a protein kinase (Roberts et al., 1994) and that BUB2, BUB3 (Hoyt et al., 1991) , and MAD2 (Chen, R-H., and A. W. Murray, unpublished results) encode proteins with unknown biochemical functions. Here we report the cloning of the MAD1 gene and show that it encodes a novel nuclear phosphoprotein that is an essential component of the spindle assembly checkpoint, but is not essential for growth under normal conditions. We find that this protein is hyper-phosphorylated in conditions that activate the spindle assembly checkpoint. The hyperphosphorylation of Madlp is only seen in a subset of mad and bub mutants allowing us to provisionally order the function of the known BUB and MAD genes. Table 1 lists the strains used in this work. The original madl mutants were isolated in the A364A background. All other strains are derivatives of W303, except the bub3A strain MAY 2072 (Hoyt et aI., 1991) and the tub2-403 (KH 152) and corresponding TUB2 control (KH146) strain which are $288C derived. Media were prepared and genetic manipulations were performed as described (Sherman et al., 1974) . Stock solutions of inhibitors were: benomyl 30 mg/ml in DMSO (added to hot media to maintain solubility), hydroxyurea 200 mg/ml in water, and a-factor 10 mg/ml in DMSO. Microcolony assays were carried out as previously described (Li and Murray, 1991) .
Materials and Methods

Yeast Strains and Media
Cloning of MAD1
Earlier attempts to clone the MAD1 gene using centromeric and multicopy libraries were unsuccessful, although we isolated a number of multicopy suppressors that conferred benomyl resistance on a variety of mad mutants and a mutant (cinlA) with defects in microtubule polymerization (Stearns et al., 1990) . These suppressors included the transcription factors YAP1 (also named PAR1, SNQ3, and PDR4) and CAD1 along with a novel member of the hsp70 family, whose sequence will be reported elsewhere. The two transcription factors had been previously isolated in multi-copy suppressor screens due to their ability to confer multi-drug resistance on yeast cells (Moye-Rowley et al, 1989; Hussain and Lenard, 1991; Schnell et al., 1992; Wu et al., 1993) .
Assuming that the MAD1 gene was not present, or was at best poorly represented, in the available libraries, we constructed a new YCP50-based genomic library. We prepared genomic DNA as previously described (Philippsen et al., 1991) from W303 strain KH 34, carried out a partial Sau3A digest, isolated 6-10-kb fragments, and ligated them to BamHI cut and phosphatase-treated YCP50 (Rose et al., 1987) . This ligation was transformed into Escherichia coli strain XL1-Blue MRF (Stratagene, La Jolla, CA) and four pools of ~10,000 colonies each were used to isolate plasmid DNA. This library DNA was then used to transform the mad1-1 strain KH 120. After two to three days of growth on uracil-free plates the Ura ÷ yeast transformants were scraped off, diluted, and replated onto YPD plates containing 10 Ixg/ml benomyl. Plasmid DNA was prepared (Ward and Kirschner, 1990 ) from benomyl-resistant colonies and individual plasmid isolates were re-tested for their ability to confer benomyl resistance to KH 120. One plasmid, pKH130, with a 6.2-kb insert, had this property. A 3.2-kb HindlII-SalI fragment from this plasmid was sufficient to complement madl strains. This fragment contained unique XhoI and XbaI sites. When either the XhoI or the XbaI restriction site was filled in, the resulting clone no longer complemented the madl mutant, suggesting that these sites lay within, or near, the complementing gene.
To check that the HindlII-Sall fragment contained the MAD1 gene rather than a suppressor we cloned the flanking HindlII fragment into the URA3-containing integration vector pRS306 (Sikorski and Hieter, 1989) . This construct was cut with BgllI then transformed into the mad1, ura3 strain, KH 120, to create a mad1 strain in which the genomic locus of the cloned gene was marked with URA3. This strain was then mated with KH 35, a MAD1, ura3 strain, the resulting diploids were sporulated and tetfads were dissected. In 10 tetrads the mad phenotype co-segregated with the Ura + spores, confirming that the sequences in pKH130 are closely linked to MAD1.
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Sequencing, Mapping, and madl Gene Disruptions
We sequenced the whole of the 3,188-bp HindIII-Sal! fragment, after subcloning various fragments into pBluescript and making ExoIII deletion series (Henikoff, 1984) . We found a single large open reading frame that is predicted to encode a protein of 749 amino acids. The sequence of this reading frame was completed and confirmed on the second strand using specifically designed primers.
The MAD1 reading frame was used to make a digoxygenin-labeled probe with a DNA labeling kit (Boehringer-Mannheim Corp., Indianapolis, IN) following the manufacturers instructions. This was used to probe a set of filters purchased from the American Type Culture Collection (Rockville, MD) that have DNA from lambda and cosmid clones covering over 96% of the genome of Saccharomyces cerevisiae cross-linked to them. The MAD1 probe specifically recognized a single lambda clone (70269) thereby mapping it to the left arm of chromosome VII between RAD6 and CYH2.
Two mad1 gene disruptions were made (see Fig. 1 ): one, madlA.1, replaces the HinclI fragments from nucleotides 994 to 2,186 with a BamHI fragment containing the HIS3 gene (pKH149). The other, madlA.2, replaces almost the complete MAD1 reading frame from the BgllI site at position 76 to the XmnI site at 1911 with the URA3 marker (pKH160). These constructs were used to transform haploid and diploid strains (KH 34, 35, and 36) . Benomyl-sensitive haploid transformants were recovered and the gene disruptions confirmed using both PCR and Western blotting analyses (see Fig. 4 ).
Preparation of Antibodies against Madlp, Immunoblotting, and Immunofluorescence
The BgllI fragment encoding residues 27 to 310 of Madlp was cloned into the BamHI site of pGEX3X (Smith and Johnson, 1988) . This glutathione-S-transferase (GST) 1 fusion construct was transformed into E. coli strain HB101 and its expression induced with 0.1 mM IPTG for 3 h at room temperature. Cells were pelleted and resuspended on ice with PBS (140 mM Na2HPO4, 1.8 mM KH2PO4, 138 mM NaCI, 2.7 mM KCI, pH 7.2), repelleted, and frozen in liquid nitrogen. The frozen cells were resuspended in five volumes of PBS containing i mM EDTA, i mM EGTA, i mM MgCI2, 1 mM PMSF, 200 p.g/ml lysozyme, and 5 v.g/ml DNase. To complete their lysis the cells were sonicated briefly. KC1 was added to 0.25 M and DTT to 15 mM and the lysate was spun at 35,000 rpm in a rotor (model 50.2 Ti; Beckman Instruments, Palo Alto, CA) for 1 h. The supernatant was then loaded onto a 10 ml glutathione agarose column (Sigma Chemical Co., St. Louis, MO) which was then washed with PBS containing 0.25 M KCI and 0.5 mM DTr. The Madl-GST fusion protein was eluted with 5 mM reduced glutathione in 50 mM Tris, pH 8.1, 0.25 M KC1. The peak fractions Were dialyzed extensively into 50 mM Hepes, pH 7.6, 50 mM KCI, 30% glycerol. This protein was sent to Berkeley Antibody Company (Berkeley, CA) where it was used to immunize a rabbit. The rabbit serum was passed over a 50 ml column of GST fusion protein coupled to Affigel I0 (Bio-Rad Labs, Hercules, CA) to remove anti-GST antibodies, then affinity purified using a 5 ml column of the Madlp-GST fusion protein coupled to Affigel 10.
Yeast extracts for immunoblotting were made by bead-beating cells in SDS sample buffer (80 mM Tris, pH 6.8, 2% SDS, 10% glycerol, 10 mM EDTA, 0.0013% Bromphenol blue, 50 mM NaF, 100 IxM NaVanadate, 1 mM PMSF and LPC [10 ixg/ml leupeptin, pepstatin, and chymostatin]). Standard methods were used for SDS-PAGE and protein transfer to nitrocellulose (Harlow and Lane, 1988) . Blots were stained with Ponceau S to confirm transfer and equal protein loading, then blocked for 30 min with blotto (4% dried milk, PBS, 0.1% Tween 20). The affinity-purified anti-Madlp antibody (0.5 mg/ml glycerol stock) was used at a dilution of 1:5,000 in blotto, and the anti-Clb2p antibody (1 mg/ml glycerol stock; kindly provided by Doug Kellogg, University of California, Santa Cruz, CA) at 1:1,500, either overnight at 4°C or for 2 h at room temperature. After washing extensively in PBS the blots were then incubated with HRPconjugated anti-rabbit antibodies (Amersham Corp., Buckinghamshire, UK) at a 1:5,000 dilution, washed again, and developed using Amersham ECL detection reagents following the manufacturer's instructions.
The affinity-purified anti-Madlp antiserum still recognizes a number of other proteins in addition to Madlp on immunoblots of whole yeast cell
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GST, glutathione-S-transferase; LPP, lambda protein phosphatase. extracts including a prominent band at 85 kD (see Fig. 4 ). However, these cross-reacting proteins are not immunoprecipitated by the antibody (see Fig. 9 ), nor are they recognized well in formaldehyde-fixed yeast cells (see Fig. 5 ), suggesting that they are unlikely to be closely related to Madlp. Attempts have been made to reduce the background on the immunoblots, by using higher salt concentrations and other blocking agents such as BSA, but the conditions used here provide the optimal detection of Madlp and its hyperphosphorylated forms.
For solubility studies, spheroplasts were prepared by treating logarithmically growing cells (KH 34) with 100 mM Tris, pH 9.4, 10 mM DT'F for 10 min at room temperature, and then digesting the cell wails with lyticase in YPD containing 0.7 M sorbitol and 10 mM Tris, pH 7.4, for 15 min at 30°C. Spheroplasts were washed and allowed to recover for 30 min at room temperature in YPD containing 0.7 M sorbitol, washed in ice-cold lysis buffer (0.2 M sorbitol, 20 mM Hepes, pH 6.8, 50 mM KOAc, 2 mM EDTA, 0.5 mM EGTA, LPC, 1 mM PMSF), and then dounced 20 times. This homogenate was spun at 7,000 g in a Beckman TL100.3 rotor and the pellet resuspended in lysis buffer and dounced and spun once again to remove any remaining whole cells and debris. DTT was added to 1 mM to the pooled supernatants, and aliquots were treated with the following: 1% Triton X-100, 1 M NaCI or 1% Triton X-100 with 1 M NaC1 and 0.25 rag/ ml DNase/RNase. After 60 min the extracts were spun at 50,000 rpm in a Beckman TL100.2 rotor for 30 min. The supernatant fractions were precipitated with TCA and equivalent fractions of pellet and supernatant fractions separated by SDS-PAGE.
For gel filtration, yeast extracts were made by bead-beating whole cells (KH 34) in 50 mM Hepes, pH 7.6, 25 mM KCI, 50 mM NaF, 1 mM MgC12, 1 mM EGTA, 0.1% NaDeoxycholate, 10% glycerol, LPC, 1 mM PMSF, 0.5 mM DTI'. The lysate was spun briefly to remove the glass beads and cell debris and then spun for 30 min at 55,000 rpm in a Beckman TL100.2 rotor. 200 p.1 was loaded on to a Superose 6 HR 10/30 column (Pharmacia Biotech Inc., Piscataway, NJ) running at 0.3 ml/min and 0.5 ml fractions were collected. For sucrose-gradient centrifugation a bead-beaten extract was made in 50 mM Hepes, pH 7.6, 50 mM KC1, 50 mM NaF, 1 mM MgCI 2, 1 mM EGTA, 0.1% NaDeoxycholate, LPC, I mM PMSF, 0.5 mM DTT, and spun for 30 min at 55,000 rpm in a TL100.2 rotor. A 2 ml sucrose gradient (5--40%) was made using a SG5 gradient mixer (Hoefer Scientific Instruments, San Francisco, CA), 100 p.l of extract was loaded on top, and spun in a TLS55 swinging-bucket rotor at 55,000 rpm for 14 h. 75 l.d fractions were taken from the top of the gradient. The sucrose gradient and the gel filtration column were calibrated with markers from a Pharmacia high molecular weight calibration kit.
For immunofluorescence, spheroplasts were prepared as above then fixed with 3.7% formaldehyde for 5 to 30 min, gently sedimented, washed, and resuspended in 0.7 M sorbitol, 0.1 M KPO4, pH 7.5, before being attached to poly-lysine--coated multi-well microscope slides. The slides were plunged into methanol (-20°C) for 5 min and acetone (-20°C) for 30 s, and then allowed to air dry. After washing with PBS, cells were blocked for 30 min with blotto, and then stained overnight at 4°C with primary antibody diluted (1:5,000 for anti-Madlp, 1:200 for anti-tubulin, 1:1,000 for anti-Raplp, 1:2,000 for mAb 414) in blotto. Ceils were washed several times with blotto and then incubated for 1 h at room temperature with a 1:50 dilution of FITC or rhodamine-labeled anti-rabbit, mouse or rat secondary antibodies from Cappel (Organon Teknika Corp., Durham, NC). After washing with blotto and then PBS, the DNA was stained with 1 Ixg/ ml DAPI in PBS and cells were mounted in 90% glycerol, 1 mg/ml phenylenediamine, pH 9.0. Coverslips were sealed with clear nail polish and slides stored at -20°C.
Phosphate Labeling and Phosphatase Digestion
Cells were grown overnight in low-phosphate YPD medium (Rubin, 1975) , diluted into fresh medium and grown to log phase. 1 mCi [32p]orthophosphate (Amersham Corp.) was added to 5 ml cultures which were shaken at room temperature for one hour. Cells were pelleted, washed, and resuspended on ice in RIPA buffer (50 mM Hepes, pH 7.6, 150 mM NaC1, 1% Triton-X 100, 1% NaDeoxycholate, 0.1% SDS, 1 mM PMSF, LPC, 1 mM DTT, 50 mM NaF, 1 mM NaVanadate). An equal volume of glass beads was added and the cells were bead-beaten for 2 min at 4°C. Extracts were clarified, diluted to 1 ml with RIPA buffer and then 1 i~1 of anti-Madlp antibody and 10 ILl of protein A-Sepharose 6MB (Pharmacia) beads were added and incubated overnight at 4°C. Immunoprecipitates were washed several times with RIPA buffer, twice with PBS and once again with RIPA before heating the beads in sample buffer and separating the sample by SDS-PAGE. Gels were stained, fixed, dried down, and exposed to film overnight at -80°C.
For lambda protein phosphatase (LPP) treatments whole cell extracts were made by bead-beating yeast cells for 2 min in lysis buffer (50 mM Hepes, pH 7.6, 75 mM KCI, 1 mM MgCI~, 1 mM EGTA, 0.1% NP40, 1 mM PMSF, LPC, 50 mM NaF, I mM NaVanadate) and DTI" was added to 1 mM after clarification. Madlp was immunoprecipitated as described above and the immunoprecipitate was washed three times with lysis buffer, twice with PBS and then with LPP reaction buffer (50 mM Tris, pH 8.0, 2 mM MnC12, 1 mM PMSF, LPC, 1 mg/ml acetylated BSA). 20 U of lambda protein phosphatase (New England Biolabs Inc., Beverly, MA) were added to the Madlp immunoprecipitate in 50 txl of LPP reaction buffer and incubated for 30 min at 30°C. Phosphatase inhibitors were 2 mM ZnCI2, 1 mM NaVanadate and 50 mM NaF. The Sepharose beads were then spun down and heated in sample buffer before separating the sample by SDS-PAGE and analyzing Madlp by immunoblotting.
Results
MAD1 Is Predicted to Encode a Novel Coiled-Coil Protein
We cloned the wild-type MAD1 gene by complementing the benomyl sensitivity of the madl-1 mutant. The complementing plasmid rescued all three madl alleles, did not rescue other benomyl sensitive mutants, and contained a DNA fragment that is closely linked to the MAD1 gene (see Materials and Methods). Sequencing the minimal complementing DNA fragment revealed a 2,250-bp reading frame which spans both an XhoI site and an XbaI site. Filling in either the XhoI site or the XbaI site destroyed the ability of this fragment to complement madl. Two gene disruptions were made, one replacing the 3' half of the MAD1 gene with HIS3 and a second that replaced almost the whole reading frame with the URA3 gene (see Fig. 1 and Materials and Methods). These constructs were used to transform haploid and diploid yeast strains. The disrupted haploid strains grow as well as wild-type cells at all temperatures tested, are sensitive to anti-microtubule drugs (see Fig. 3 a) , and are unable to complement the madl alleles previously isolated confirming that the disrupted reading frame is indeed MAD1.
The DNA sequence and predicted translation of MAD1 is shown in Fig. 2 a. The amino acid indeed have a high probability of forming coiled-coil (see Fig. 2 b) (Lupas et al., 1991) . The sequence of Madlp also contains a putative bi-partite nuclear localization sequence (residues 506-527) (Dingwall and Laskey, 1991) , many potential phosphorylation sites and an unusual stretch rich in asparagine residues (residues 330-372).
The MAD1 Gene Encodes a Component of the Spindle Assembly Checkpoint
We studied madlA strains for defects in the spindle assembly checkpoint. The benomyl sensitivity of the original mad mutants could be rescued with hydroxyurea, a drug that lengthens S phase (Li and Murray, 1991 their mitotic spindle before initiating anaphase. Although 1 mg/ml hydroxyurea slightly decreases the benomyl sensitivity of wild-type cells, it does not rescue the benomyl sensitivity of mutants with defects in microtubule polymerization, such as cinlA (Fig. 3 a) , even at lower concentrations of benomyl (data not shown). Fig. 3 a shows that the madlA.1 deletion mutant behaves like the original madl and mad2-1 alleles: at 23°C it is sensitive to benomyl at concentrations of 7.5 ixg/ml and above, and this benomyl sensitivity can be rescued by i mg/ml hydroxyurea. We used microcolony assays to monitor the initial rate of cell division of madlA.1 strains on benomyl-containing medium. Individual, unbudded cells were picked with a dissecting needle and their growth on plates containing 12 Ixg/ml benomyl was analyzed over a period of 8 hours. Fig.  3 b shows that, like the original madl alleles, the madla.1 strain initially divided faster than the wild-type control cells. This behavior of madla.1 differs radically from strains with defects in microtubule polymerization, which are unable to divide in the presence of benomyl and arrest as large budded cells. This result is consistent with madlA.1 cells being unable to sense or respond to the disruption of their microtubules and thus initiating anaphase before spindle assembly is complete. It has previously been shown that mad mutants fail to maintain the mitotic activity of Cdc28p (monitored as histone H1 kinase activity) when they are treated with benomyl (Li and Murray, 1991) . We have confirmed this result with madlA.1 (data not shown).
Madlp Is a Soluble Nuclear Protein
To analyze the properties of Madlp we raised polyctonal antibodies, against a GST fusion protein that contained the amino-terminal half of Madlp. The serum was affinity purified and used to probe Western blots of whole cell extracts from a number of yeast strains. Fig. 4 a shows that a protein of 90 kD that is seen in the wild-type cell extract is absent from the m a d l z l l strain, and present at higher levels in strains containing M A D 1 plasmids. A truncated Madl protein is expressed in madlA.1 where the 3' end of the M A D 1 gene has been removed, and in two of the three previously isolated mad1 alleles (Fig. 4 b) . The latter finding provides strong evidence that the reading frame we have identified is indeed the M A D 1 gene and that the antiserum efficiently recognizes both wild-type and a number of mutant Madl proteins. The affinity-purified antiMadlp antiserum still recognizes a number of other proteins in addition to Madlp on immunoblots of whole yeast cell extracts, including a prominent band at 85 kD. However, the cross-reacting proteins are not immunoprecipitated by the antibody (see Fig. 9 ), nor are they recognized well in formaldehyde-fixed yeast cells (Fig. 5) , suggesting that they are unlikely to be closely related to Madlp.
Immunofluorescence with affinity-purified anti-Madlp antibodies was used to localize Madlp within yeast cells. Fig. 5 reveals that the bulk of Madlp appears as discrete patches in the nucleus. The reactivity of Madlp is sensitive to fixation. We found that greater than 5 min of formaldehyde fixation dramatically reduced Madlp staining and further fixation completely abolished it (data not shown). We used a number of antibodies to confirm that the structure of the yeast nucleus was relatively intact after fixation. Fig. 5 (e-j) shows that antibodies to tubulin (Adams and Pringle, 1984) and to the 90-kD component of the spindle-pole body (Rout and Kilmartin, 1990 ) gave the previously reported patterns, and that there was no consistent co-localization of these proteins with Madlp. In addition, we found no co-localization of Madlp with Raplp (a telomere protein; Klein et al., 1992) or nuclear pore antigens (data not shown). Although we observed coincident localization of some of the Madlp staining and spindle pole bodies in a few cells, we conclude that Madlp has a novel nuclear localization pattern.
Since some coiled-coil proteins form large insoluble oligomeric structures (Fuchs, 1994) we tested the solubility of Madlp. Yeast extracts were made by preparing spheroplasts, douncing them and then extracting the homogenate with buffers containing various salts, detergents and nucleases. The extracts were then spun at 100,000 g to separate soluble from insoluble material. Pellet and supernatant fractions were then run on SDS gels and blotted for Madlp (Fig. 6) . Under all conditions the bulk of Madlp was found in the supernatant, but we reproducibly found that a minor fraction pelleted. However, even this fraction could be solubilized by a combined treatment with 1% Triton/1 M NaC1/DNase and RNase, suggesting that Madlp is unlikely to be a constituent of the nuclear scaffold (Mirzayan et al., 1992) .
Another striking characteristic of coiled-coil proteins is (Fig. 6 c) .
Neither the sedimentation nor the gel filtration behavior of Madlp was altered by the presence of 1 M NaC1 (not shown). Similar fractionation behavior has been reported Wild-type (KH 34) cells were arrested with a-factor and then released into YPD or YPD containing 15 Ixg/ml benomyl. Cells were taken at the times indicated and extracts were immunoblotted using anti-Madlp and anti-Clb2p antibodies.
for other coiled-coil proteins, such as myosin and kinesin (Hackney et al., 1992; Hirano and Mitchison, 1994) . We therefore propose that Madlp has a large Stokes' radius and that it may be rod shaped, consistent with the elongated structure of many coiled-coil proteins.
Modification of Madlp by Phosphorylation
Does cell cycle progression or activation of the spindle assembly checkpoint alter the abundance or posttranslational modification of Madlp? To answer these questions we examined cells released from a G1 arrest into normal or benomyl containing medium. Wild-type cells were arrested in G1 with a-factor and then released into YPD or YPD containing 15 p~g/ml benomyl. Samples were collected over two cell cycles and analyzed for the abundance of Madlp by immunoblotting. To monitor the timing of the cell cycle, these blots were also probed with antibodies to the mitotic cyclin Clb2p which is degraded at the end of mitosis. Fig. 7 shows that the abundance of Madlp remains constant through the cell cycle and is not affected by benomyl-induced mitotic arrest. During a normal cell cycle there is only a minor variation in the gel mobility of Madlp, however a significant fraction of the protein decreases in gel mobility when cells are arrested in mitosis by benomyl treatment (similar results were obtained with nocodazole; data not shown). The low level of Madlp modification seen in untreated cells may be induced by transient spindle defects that occur in the course of normal spindle assembly. Figs. 9 and 10 clearly demonstrate that the slower migrating bands are forms of Madlp and not cross-reacting proteins that accumulate in mitosis.
The slower migrating form of M a d l p appears in mitotically arrested cells whose levels of Clb2p are high, suggesting that modification of M a d l p is a specific response to a disrupted spindle. To test this hypothesis we asked whether Madlp was modified when cells arrested at Start with a-factor were treated with benomyl (Fig. 8 a) . Half of the a-factor-arrested cells were treated with 30 ixg/ml benomyl in the continuous presence of a-factor to prevent their passage through Start. The other half were released from their a-factor arrest into YPD containing benomyl. Fig. 8 a shows that benomyl treatment of cells maintained at the a-factor arrest point causes much less modification of Madlp than releasing cells from a-factor arrest into benomyl. The low level of M a d l p modification seen after 2 h of combined treatment with a-factor and benomyl probably represents a fraction of the cells that have broken through the a-factor arrest. This experiment shows that the modification of Madlp is not simply a response to benomyl, but is seen only in cells in the portion of the cell cycle where spindle assembly can occur.
To determine whether other mitotic arrests are accompanied by Madlp modification, we analyzed Madlp in number of other mutants. Fig. 8 b shows that the modification of Madlp is not seen in either cdc23 mutants which prevent the ubiquitin-mediated proteolysis necessary to initiate anaphase and thus arrest early in mitosis with short spindles (Irniger et al., 1995) , or in cdc15 mutants which arrest later in mitosis with long spindles (Surana et al., 1993) . This result demonstrates that Madlp modification requires spindle perturbations in addition to an arrest with high levels of Cdc28-Clb-associated kinase activity.
To test whether other methods of disrupting spindle microtubules lead to the modification of Madlp, we compared synchronous cultures of wild-type and cold-sensitive tub2-403 strains (Huffaker et al., 1988 ) that had been arrested with a-factor and then released at 15°C. Fig. 8 c shows that the tub2 mutant arrests in mitosis with high levels of Clb2p and that a significant fraction of Madlp is modified. In addition, we note that Madlp is transiently modified in the wild-type cells, and that this occurs before the levels of Clb2p peak, when the spindle is presumably being assembled. Such modification can be seen in wildtype cells growing at higher temperatures (see Fig. 7 ) but is less obvious, consistent with it being a response to temperature-induced spindle perturbations (Dustin, 1984) .
Is the reduced gel mobility of Madlp due to phosphorylation? To test this possibility we immunoprecipitated Madlp from logarithmically growing and benomyl-arrested cells and treated the immunoprecipitates with lambda protein phosphatase. Fig. 9 a shows that phosphatase treatment eliminates the slower migrating forms of Madlp, consistent with the reduced mobility resulting from phosphorylation. Treatment with lambda protein phosphatase in the presence of phosphatase inhibitors has no effect on the gel mobility of Madlp. As not all protein phosphorylations are accompanied by a gel shift we also analyzed Madlp in cells that were metabolically labeled with [32p]orthophosphate. Extracts were prepared from exponentially growing or cell cycle-arrested cultures, immunoprecipitated with the polyclonal anti-Madlp antiserum, and analyzed by gel electrophoresis and autoradiography. Fig. 9 b shows that phosphate incorporation into Madlp occurs to equal extents in exponentially growing, benomyl-arrested, and a-factor-arrested ceils, suggesting that Madlp is phosphorylated throughout the cell cycle. Our inability to see more slowly migrating phosphate labeled forms of Madlp in benomyl-treated cells may reflect the relatively low level of labeling, or the poor mitotic arrest produced by benomyl treatment in low phosphate medium, or both.
We also examined the phosphorylation of the N-terminal half of Madlp that is expressed in the madlA.1 strain. Although 32p is incorporated into this fragment as efficiently as it is into the wild-type protein (Fig. 9) , none of the original mad1 alleles nor this truncated protein (not shown) show the mobility shift that occurs when wild type cells are treated with benomyl ( Fig. 10 a) . These findings indicate that Madlp is the target for two types of phosphorylation: constitutive phosphorylation that appears to occur throughout the cell cycle and on both functional and Wild-type cells (KH 34) were grown in low phosphate YPD medium or the same medium containing either 10 p.g/ml a-factor or 30 ~g/ml benomyl. (KH 128) , and bub3A (MAY 2072) strains were grown to log phase, and then treated with 30 ~g/ml benomyl for 3 h. Whole cell extracts were made and immunoblotted with anti-Madlp.
non-functional forms of Madlp, and a regulated phosphorylation that is induced by activation of the spindle assembly checkpoint and occurs only on functional Madlp.
We asked whether Madlp was hyperphosphorylated in mutants defective in the spindle assembly checkpoint. To do this we examined the gel mobility of Madlp in extracts made from wild type, mad, or bub strains that were grown in the absence or presence of 30 ixg/ml benomyl. Fig. 10 b shows that Madlp hyper-phosphorylation was undiminished in the mad3A and bub2A mutants, from which we conclude that neither Mad3p nor Bub2p are necessary for this modification of Madlp. However, the hyperphosphorylation of Madlp was dramatically reduced in mad2-1, and absent in the bublA and bub3A mutant strains. This shows that Bublp, Bub3p, and Mad2p are all important for this modification of Madlp. The observation that Bublp is a novel protein kinase (Roberts et al., 1994) prompted us to ask whether this protein is required for all phosphorylation events on Madlp. Madlp is still phosphate labeled in the bublA strain showing that Bublp is not required for the addition of all phosphate groups to Madlp (Fig. 9 b) .
Discussion
We have cloned the MAD1 gene and shown that it encodes a novel nuclear phosphoprotein that is predicted to form coiled-coils. Like the previously isolated madl alleles, madlA cells are unable to delay initiation of anaphase in response to microtubule depolymerization and thus suffer a high frequency of chromosome loss and rapid death upon treatment with anti-microtubule drugs. Spindle disruption is accompanied by a Madlp phosphorylation that reduces the mobility of the protein and this modification requires the Bublp, Bub3p and Mad2p functions, but not Bub2p and Mad3p, suggesting that this phosphorylation plays an important role in the spindle assembly checkpoint.
Antibodies to Madlp reveal that the protein has a nonuniform distribution within the nucleus. All cells show a diffuse punctate staining and many also have a small number of brightly staining loci. Neither staining pattern reproducibly colocalizes with nuclear pores, spindle-pole bodies or telomeres, suggesting that the Madlp may be found at a novel location within the nucleus. Identifying the Madlp-containing structures will require immunoelectron microscopy or isolating Madlp homologs from organisms with better cytology. In cell extracts Madlp is largely soluble, and its hydrodynamic behavior suggests that Madlp has an elongated shape like many other coiled-coil proteins.
Analyzing the gel mobility and phosphate labeling of Madlp has revealed both a constitutive level of phosphorylation, seen in all stages of the cell cycle that we analyzed, and a hyper-phosphorylation induced by spindle depolymerization. The former phosphorylation is seen in exponentially growing cells as well as in G1 and mitotically arrested cells, suggesting that it occurs throughout the cell cycle. We do not know the identity of the constitutive phosphorylation site(s), or whether their modification plays any role in the spindle assembly checkpoint. The regulated phosphorylation reduces the gel mobility of Madlp and is seen only in those parts of the cell cycle in which cells are able to assemble a spindle. The modification is detectable at a low level in normally growing cells, and is much more pronounced in benomyl treated cells suggesting that it may be induced by activation of the spindle assembly checkpoint. The low level of Madlp hyperphosphorylation in wild type cells could either reflect full activation of the spindle assembly checkpoint in a small fraction of the population with transient spindle defects, or weak activation in all cells during the course of spindle assembly. We find that wild-type cells growing in the cold show higher levels of Madlp modification, and that the tub2-403 mutant arrests in the cold in mitosis with hyperphosphorylated Madlp, showing that Madlp modification is not solely a response to drug-induced spindle perturbations. In addition we find that Madlp receives little modification in cdc23 and cdc15 mutant arrests, ruling out the possibility that the hyperphosphorylation of Madlp is simply a byproduct of any cell cycle arrest with active Cdc28-Clb2 complexes. But if cdc23 mutants are first arrested at 37°C and then treated with benomyl without releasing them from the arrest Madlp does become hyperphosphorylated (data not shown), showing that spindle disassembly at this metaphase-like arrest can be readily detected by the checkpoint.
Examining Madlp hyper-phosphorylation in mad and bub mutants strengthens the case that this modification plays an important role in the spindle assembly checkpoint. There is no mobility shift in mad1-1, mad1-2, mad1-3, or madlA.1. This observation suggests that the proper function of Madlp is needed for its own modification and is especially significant for mad1-2, which encodes an apparently full length protein. The modification of wild-type Madlp does not occur in the bubl and bub3 mutants and is strongly reduced in the mad2 mutant. Although the correlative evidence is strong, proof that Madlp hyperphosphorylation is necessary for the spindle assembly checkpoint will require the identification and mutation of the regulated Madlp phosphorylation sites.
We assume that the spindle assembly checkpoint must consist of at least three classes of component: a detection system that monitors the structure of the spindle, a signal transduction pathway that relays this information, and a target in the cell cycle machinery whose regulation can produce a mitotic arrest. Even if the mobility shift of Madlp is no more than a correlation with the activation of the spindle assembly checkpoint, it represents the first tool for ordering the functions in this pathway. The simplest interpretation of our data is that Madlp lies ia the middle of the checkpoint pathway and that mutants that fail to hyperphosphorylate this protein identify proteins that act upstream of Madlp, whereas mutants that can modify Madlp identify proteins that act downstream of Madlp (Fig. 11) . Clearly our results do not allow us to rule out other more complicated models. For example, Bub2p and Mad3p need not be directly downstream of Madlp but could instead be in a parallel pathway whose action is required for cell cycle arrest but not for the hyperphosphorylation of Madlp. The isolation of dominant alleles of MAD1, and of the other MAD and BUB genes, that cause a mitotic arrest should enable us to order the function of these genes within the spindle assembly checkpoint more precisely. Previous work identifies three candidates for the physiological Madlp kinase. The demonstration that Bublp is a protein kinase that can phosphorylate itself and Bub3p in vitro (Roberts et al., 1994) , and the inability of bubl cells to hyperphosphorylate Madlp make Bublp a good candidate for a Madlp-kinase. The MPS1 gene product is another candidate, since it has protein kinase activity in vitro and is required for the spindle assembly checkpoint to detect defects in spindle pole body duplication (Weiss, E., and M. Winey, personal communication). Finally, the observation that activation of the spindle assembly checkpoint in frog egg extracts requires the activities of MAP kinases suggests that members of this kinase family are also candidates for the Madlp kinase (Minshull et al., 1994) . By identifying the sites of benomyl-dependent Madlp phosphorylation we hope to determine their role in the spindle assembly checkpoint and to identify the kinases and phosphatases that regulate this modification.
